Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses

• Published in: Immunological reviews Vol. 264; no. 1; pp. 288 - 307
• Main Authors: Lenaerts, Anne, Barry III, Clifton E., Dartois, Véronique
• Format: Journal Article
• Language: English
• Published: England Blackwell Publishing Ltd 01.03.2015; BlackWell Publishing Ltd
• Subjects: animal models; Animals; Antitubercular Agents - pharmacology; Antitubercular Agents - therapeutic use; biomarkers; Disease Models, Animal; Granuloma - drug therapy; Granuloma - immunology; Granuloma - pathology; Host-Pathogen Interactions - immunology; Humans; immunopathology; Invited Reviews; Latent Tuberculosis - immunology; Latent Tuberculosis - pathology; lesion dynamics; Mycobacterium tuberculosis - immunology; Treatment Outcome; tuberculosis; Tuberculosis - drug therapy; Tuberculosis - immunology; Tuberculosis - pathology; lesion dynamics; animal models; immunopathology; biomarkers; tuberculosis
• ISSN: 0105-2896; 1600-065X
• DOI: 10.1111/imr.12252

Summary Tuberculosis (TB) lesions are extremely complex and dynamic. Here, we review the multiple types and fates of pulmonary lesions that form following infection by Mycobacterium tuberculosis and the impact of this spatial and temporal heterogeneity on the bacteria they harbor. The diverse immunopathology of granulomas and cavities generates a plethora of microenvironments to which M. tuberculosis bacilli must adapt. This in turn affects the replication, metabolism, and relative density of bacterial subpopulations, and consequently their respective susceptibility to chemotherapy. We outline recent developments that support a paradigm shift in our understanding of lesion progression. The simple model according to which lesions within a single individual react similarly to the systemic immune response no longer prevails. Host‐pathogen interactions within lesions are a dynamic process, driven by subtle and local differences in signaling pathways, resulting in diverging trajectories of lesions within a single host. The spectrum of TB lesions is a continuum with a large overlap in the lesion types found in latently infected and active TB patients. We hope this overview will guide TB researchers in the design, choice of read‐outs, and interpretation of future studies in the search for predictive biomarkers and novel therapies.